The rise of Sildenafil initially drove a period of growth for the drug industry, but recent changes present a murky outlook for investors. Lower-cost alternatives are eroding earnings, and persistent patent challenges https://jimtxox577225.blog2freedom.com/41283899/viagra-and-pharma-a-volatile-bet